Physician Quality Reporting


Starting in 2016, individual-level QCDR measures will be available for public reporting. In 2017, both individual and group-level QCDR measures will be available for public reporting. Publicly reporting QCDR data on Physician Compare expands the quality measure data available for EPs and group practices regardless of specialty and provides more quality data to consumers to help them make informed decisions.

What QCDR measures are available for public reporting?

In late 2017, all 2016 individual-level QCDR data, including MIPS and non-MIPS measures, will be available for public reporting. First-year measures will not be publicly reported and all data must meet the public reporting standards to be included on the website. The criteria require that the measures must:

  • Be statistically valid and reliable, accurate, and comparable
  • Have a minimum sample size of 20 patients
  • Resonate with consumers

2016 Non-MIPS QCDR Measures Description

ASBrS 1 The surgeon considers whether a gene could be the cause of a patient’s breast cancer.
One possible cause of breast cancer is a gene that has changed (also called an inherited genetic mutation). Genetic tests can show if there is a mutation. If a mutation is present, this can affect the type of breast surgery that is done. It can also show the risk of developing other cancers in other organs, and it can provide information for other family members about their health risks. To get this healthcare score, the number of cancer patients for whom a surgeon considers a genetic cause is divided by the total number of cancer patients seen. Higher percentages are better because it means your surgeon thinks about genetic causes of breast cancer.

2016 QCDR Public Reporting